Patent details

EP3498297 Title: PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF AUTISM

Basic Information

Publication number:
EP3498297
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Unitary Effect Registered
Application number:
EP182047639
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF AUTISM
French Title of Invention:
COMPOSITIONS PHARMACEUTIQUES POUR LE TRAITEMENT DE L'AUTISME
German Title of Invention:
PHARMAZEUTISCHE ZUSAMMENSETZUNG ZUR BEHANDLUNG VON AUTISMUS
SPC Number:

Unitary Effect

Unitary Effect Requested:
Yes
Unitary Effect Request Filing Date:
20/07/2023
Link to UPP Register:
European Patent Register
Unitary Effect Request Withdrawal Date:
Unitary Effect Status:
Unitary Effect Registered
Unitary Effect Acceptance Decision Date:
26/07/2023
Unitary Effect Rejection Decision Date:
Unitary Effect Date:
21/06/2023
Unitary Effect Registration Date:
26/07/2023
Unitary Effect Re-establishment of rights Filing Date:
Unitary Effect Re-establishment of rights EPO Decision :
Unitary Effect Re-establishment of rights EPO Decision Date:
Explanatory Text UE:
Safety Net Request Date:
Safety Net Decision Date:
Safety Net Decision Outcome:
SPC Number:

Dates

Filing date:
06/11/2018
Grant date:
21/06/2023
EP Publication Date:
19/06/2019
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
21/06/2023
EP B1 Publication Date:
21/06/2023
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
06/11/2038
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
14/06/2023
 
 

Name:
Stalicla S.A.
Address:
Avenue de Sécheron 15, 1202 Geneva, Switzerland (CH)

Inventor

Name:
Durham, Lynn
Address:
Switzerland (CH)

Priority

1

Priority Number:
201762582141 P
Priority Date:
06/11/2017
Priority Country:
United States (US)

2

Priority Number:
17200219
Priority Date:
06/11/2017
Priority Country:
European Patent Office (EPO) (EP)

3

Priority Number:
201862663647 P
Priority Date:
27/04/2018
Priority Country:
United States (US)

4

Priority Number:
18169952
Priority Date:
27/04/2018
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
A61K 45/00; A61P 25/00;

Publication

European Patent Bulletin

1

Issue number:
202325
Publication date:
21/06/2023
Description:
Grant (B1)

2

Issue number:
202334
Publication date:
23/08/2023
Description:
Unitary Effect Request Receipt

3

Issue number:
202335
Publication date:
30/08/2023
Description:
Unitary Effect Request Acceptance

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages